glucagon and glp 1 Glucagon-like peptide in health disease Current Insights, Advantages and Challenges

Paracrinology of islets and the paracrinopathy of diabetes

Evidence from a multicenter, long-term cardiovascular outcome trial demonstrated that GLP-1RAs reduce mortality associated with cardiovascular disease and confer protective effects by decreasing the incidence of myocardial infarction and nonfatal stroke.104 GLP-1RAs have been shown to enhance endothelial cell function through anti-inflammatory and vasodilatory mechanisms

Regardless of the method, remember that these medications are designed to support a healthy lifestyle, not replace it

Indeed, plasma GLP-1 concentrations and their corresponding AUC were comparable between the two groups (Supplementary Fig